The Ethical Landscape of Prodromal Parkinson Disease

The Ethical Landscape of Prodromal Parkinson ...

Up next

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at t ...  Show more

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial. ...  Show more

Recommended Episodes

The Ethical Landscape of Prodromal Parkinson Disease
Neurology Minute

Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522   

Understanding Apathy in Parkinson Disease - Part 2
Neurology Minute

Dr. Jason Crowell and Dr. Campbell Le Heron discuss tips and recommendations to help improve apathy in folks with Parkinson disease. Show references:  https://www.neurology.org/doi/10.1212/WNL.0000000000209301    

Progress for Parkinson's?
Intention to Treat

This episode explores the fastest-growing neurologic condition in the world, Parkinson’s disease. What have we learned in recent years, and where are the greatest hopes for the future? A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2414003. 

Parkinson's Disease
Zero to Finals Medical Revision Podcast

In this episode I cover Parkinson's disease.

If you want to follow along with written notes on Parkinson's disease go to https://zerotofinals.com/medicine/neurology/parkinsons/ or the neur ...

  Show more